ProfileGDS4459 / ENSG00000114942
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 64% 50% 85% 64% 81% 49% 87% 78% 82% 82% 69% 80% 80% 73% 85% 71% 64% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.9564
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.3850
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.7185
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.9764
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.2681
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.3449
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.8787
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.9878
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.4182
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.3582
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.1769
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.2980
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.0980
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.3273
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.7585
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.2671
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.8964